Consultation between specialists in Internal Medicine and Family Medicine improves management and prognosis of heart failure

被引:12
作者
Gomez-Soto, Francisco M. [1 ]
Puerto, Jose L. [1 ]
Andrey, Jose L. [1 ]
Fernandez, Francisco J. [1 ]
Escobar, Miguel A. [1 ]
Garcia-Egido, Antonio A. [1 ]
Romero, Sotero P. [1 ]
Bernal, Jose A. [1 ]
Gomez, F. [1 ]
机构
[1] Univ Cadiz, Sch Med, Univ Hosp Puerto Real, Dept Internal Med, Cadiz, Spain
关键词
Heart failure; Disease management; Case management; Patient care management;
D O I
10.1016/j.ejim.2008.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: To evaluate if consultation between specialists in Internal Medicine and family doctors (CIMFD) improves the clinical management and prognosis of patients with heart failure (HF). Methods: Design: prospective case-control study (5 years of follow-up). Setting: community-based sample within the area of a university teaching hospital. Subjects: 1857 patients (>= 14 years) diagnosed for the first time with HF (1stDxHF), in the CIMFD. Control group: 1981 patients (from health centres not covered by the CIMFD), 1stDxHF, in the external consultations of the hospital. Main outcome measures: mortality rate (MR). Admissions (HA). Emergency services visits (ESV). Delays in receiving specialist attention (DRSA), and the resolution of the process (DR-P). Number (NTP) and delays in reporting (DTP) tests performed. Proportion (PRC) and delay (DRC) in resolving cases. Results: We observed a reduction of. MR (by 10.8%, CI 95%, 8.6-13.0, p < 0.005); HA, per patient per year (ppy) (by 1.8, 1.3-2.3, p < 0.0 1); ESV, ppy (by 1.9, 1.2-2.6, p < 0.01); DRSA (by 26.5 days, 21.8-31.2, p < 0.00 1); DRP (by 2 1.0 days, 18.3-23.7, p < 0.001), and DRC (by 25.8 days, 20.3-31.4, p < 0.01). The PRC (17.2%, Cl 95%, 15.5-18.9, p < 0.01) was higher for the CIMFD. Conclusion: The CIMFD approach improves prognosis and efficacy in the clinical management of patients with HF because it reduces mortality and morbidity (HA and ESV), shortens the delays in receiving care and in resolving the diagnostic and therapeutic process (DRSA, DRP, DRC), and increases the proportion of diagnosed and treated patients. (C) 2008 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:548 / 554
页数:7
相关论文
共 56 条
  • [51] STARFIELD B, 1998, PRIMARY CARE BALANCI, P344
  • [52] More 'malignant' than cancer? Five-year survival following a first admission for heart failure
    Stewart, S
    MacIntyre, K
    Hole, DJ
    Capewell, S
    McMurray, JJV
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) : 315 - 322
  • [53] Guidelines for the diagnosis and treatment of chronic heart failure:: executive summary (update 2005)
    Swedberg, K
    Cleland, J
    Dargie, H
    Drexler, H
    Follath, F
    Komajda, M
    Tavazzi, L
    Smiseth, OA
    Gavazzi, A
    Haverich, A
    Hoes, A
    Jaarsma, T
    Korewicki, J
    Lévy, S
    Linde, C
    Lopez-Sendon, JL
    Nieminen, MS
    Piérard, L
    Remme, WJ
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (11) : 1115 - 1140
  • [54] Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT
    Thackray, S
    Witte, K
    Clark, AL
    Cleland, JGF
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (02) : 209 - 212
  • [55] Heart failure in patients with preserved and deteriorated left ventricular ejection fraction
    Varela-Roman, A
    Grigorian, L
    Barge, E
    Bassante, P
    de la Peña, MG
    Gonzalez-Juanatey, JR
    [J]. HEART, 2005, 91 (04) : 489 - 494
  • [56] Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
    Yusuf, S
    Pfeffer, MA
    Swedberg, K
    Granger, CB
    Held, P
    McMurray, JJV
    Michelson, EL
    Olofsson, B
    Östergren, J
    [J]. LANCET, 2003, 362 (9386) : 777 - 781